NCT01311258View on ClinicalTrials.gov

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2030

Conditions
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Trial Locations (1)

14642

RECRUITING

University of Rochester Medical Center, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT01311258 - Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter